1. Home
  2. ULBI vs PSTV Comparison

ULBI vs PSTV Comparison

Compare ULBI & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$6.78

Market Cap

89.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.29

Market Cap

80.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
PSTV
Founded
1990
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.9M
80.4M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
ULBI
PSTV
Price
$6.78
$0.29
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
41.4K
9.4M
Earning Date
11-18-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$186,530,000.00
$5,258,000.00
Revenue This Year
$31.30
$1.73
Revenue Next Year
$6.24
$12.05
P/E Ratio
$70.13
N/A
Revenue Growth
12.94
N/A
52 Week Low
$4.07
$0.16
52 Week High
$9.52
$2.31

Technical Indicators

Market Signals
Indicator
ULBI
PSTV
Relative Strength Index (RSI) 61.00 26.25
Support Level $6.03 $0.25
Resistance Level $7.33 $0.61
Average True Range (ATR) 0.37 0.04
MACD 0.11 -0.03
Stochastic Oscillator 64.21 10.67

Price Performance

Historical Comparison
ULBI
PSTV

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: